V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330008352 | 330005137 | null | 72.8 | Curative (C) | 2014-11-30 | 2014-11-30 | Cytarabine High Dose | Y | N | 330017136 | CYTARABINE HIGH DOSE |
| 330008353 | 330005137 | 1.7 | 47.8 | Adjuvant (A) | 2017-05-12 | 2017-05-12 | Trabectedin | 02 | N | 330017136 | TRABECTEDIN |
| 330008354 | 330005137 | 1.68 | 65 | Palliative (P) | 2016-10-03 | 2016-11-08 | Cisplatin + Etoposide po&iv 3 day | N | N | 330017136 | AZACITIDINE |
| 330008355 | 330005139 | 1.55 | 52.1 | Neo-adjuvant (N) | 2015-03-08 | 2015-03-15 | Cyclophosphamide + Topotecan | 02 | null | 330017162 | CISPLATIN + ETOPOSIDE |
| 330008356 | 330008810 | 1.57 | null | Curative (C) | 2017-08-03 | 2017-08-03 | Liposomal Doxorubicin (Caelyx) | N | N | 330017168 | LIPOSOMAL DOXORUBICIN |
| 330008357 | 330010773 | null | 86.75 | Curative (C) | 2016-11-21 | 2016-11-24 | Methotrexate intrathecal | 02 | null | 330017192 | METHOTREXATE INTRATHECAL |
| 330008358 | 330005142 | null | 70.3 | Curative (C) | 2016-02-10 | 2016-02-11 | CAV | null | N | 330017192 | CISPLATIN + ETOPOSIDE |
| 330008359 | 330005144 | 1.75 | null | Curative (C) | 2013-09-21 | 2013-09-26 | NIVOLUMAB | 2 | N | 330017225 | NIVOLUMAB |
| 330008360 | 330005144 | 1.77 | 102 | Palliative (P) | 2016-07-21 | 2016-07-30 | GemCarbo Days 1+8 | 02 | N | 330017225 | GEMCARBO |
| 330008361 | 330005146 | null | 74.4 | Curative (C) | 2010-08-14 | 2013-04-08 | EW EuroEwing 2012 Arm A VIDE | null | N | 330017228 | EURO-EWING |
| 330008362 | 330005148 | 1.68 | null | Palliative (P) | 2014-08-21 | 2014-10-14 | GemCarbo Days 1+8 | N | N | 330017243 | GEMCARBO |
| 330008363 | 330005150 | 1.81 | 114 | Curative (C) | 2017-12-27 | 2017-12-27 | Cyclophosphamide + Dex + Rituximab | N | N | 330017251 | AZACITIDINE |
| 330008364 | 330005150 | 0 | 100 | Palliative (P) | 2014-03-09 | 2014-05-09 | AML Int Guide HD Cytarabine (3 + 4) | N | N | 330017251 | CYTARABINE HIGH DOSE |
| 330008365 | 330005151 | 1.75 | null | Curative (C) | 2015-09-16 | 2015-09-16 | DA 3+8 | N | N | 330017305 | NIVOLUMAB |
| 330008366 | 330011871 | 1.6 | 68.6 | Adjuvant (A) | 2016-07-30 | 2016-07-30 | Cisplatin + Doxorubicin | N | N | 330017306 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008369 | 330005160 | 1.79 | 81.4 | Palliative (P) | 2016-12-05 | 2016-12-16 | VAC | N | null | 330017338 | CAV |
| 330008370 | 330005161 | 1.75 | null | Disease modification (D) | 2014-04-10 | 2014-04-10 | VAC | 02 | N | 330017399 | DA |
| 330008371 | 330008821 | 1.79 | 68.3 | Palliative (P) | 2014-04-17 | 2014-04-21 | Methotrexate intrathecal | N | N | 330017399 | METHOTREXATE INTRATHECAL |
| 330008372 | 330005163 | 1.61 | 67 | Curative (C) | 2015-06-09 | 2015-06-09 | FLAG + Idarubicin | N | N | 330017403 | FLAG + IDARUBICIN |
| 330008373 | 330005163 | 0 | 88.7 | Curative (C) | 2015-07-26 | 2015-08-04 | Vinblastine weekly | 02 | N | 330017403 | DA |
| 330008374 | 330005164 | null | 42 | Palliative (P) | 2016-02-29 | 2016-11-28 | ETOPOSIDE | N | N | 330017431 | ETOPOSIDE |
| 330008375 | 330005167 | 1.62 | null | Palliative (P) | 2015-10-24 | 2015-10-31 | CARBOPLATIN + GEMCITABINE | N | N | 330017436 | GEMCARBO |
| 330008376 | 330005169 | 0 | 8.3 | Palliative (P) | 2016-10-23 | 2016-11-18 | Liposomal Doxorubicin (Caelyx) | null | null | 330017436 | LIPOSOMAL DOXORUBICIN |
| 330008377 | 330005169 | 1.5 | 63.5 | Palliative (P) | 2015-04-16 | 2015-04-28 | Cyclophosphamide + Topotecan | N | N | 330017436 | NIVOLUMAB |
| 330008378 | 330005169 | 1.5 | 86.1 | Curative (C) | 2015-10-20 | 2015-11-03 | EW EuroEwing 2012 Arm A VIDE | N | N | 330017436 | EURO-EWING |
| 330008379 | 330005171 | null | 67 | Palliative (P) | 2014-12-30 | 2014-12-30 | Trabectedin | null | null | 330017469 | TRABECTEDIN |
| 330008380 | 330005172 | 0 | 81.05 | Palliative (P) | 2014-05-10 | 2014-05-10 | TEMOZOLOMIDE | N | N | 330017470 | NIVOLUMAB |
| 330008381 | 330008824 | 1.63 | 89 | Palliative (P) | 2016-06-28 | 2016-06-29 | Cyclophosphamide + Dex + Rituximab | 2 | N | 330017507 | NIVOLUMAB |
| 330008382 | 330005173 | null | 67.4 | null | 2013-06-17 | 2013-06-27 | NIVOLUMAB | Y | N | 330017510 | VINBLASTINE |
| 330008383 | 330005176 | null | 75.7 | Curative (C) | 2017-06-18 | 2017-06-18 | Liposomal Doxorubicin (Caelyx) | N | N | 330017512 | LIPOSOMAL DOXORUBICIN |
| 330008384 | 330005177 | 0 | 64.5 | Palliative (P) | 2015-11-09 | 2016-07-19 | DA 3 + 10 | 02 | N | 330017513 | CISPLATIN + DOXORUBICIN |
| 330008385 | 330005178 | 0 | 66.1 | Neo-adjuvant (N) | 2015-02-25 | 2015-03-06 | NIVOLUMAB | Y | N | 330017544 | VINBLASTINE |
| 330008386 | 330005182 | 1.63 | 63.5 | Palliative (P) | 2016-08-22 | 2016-10-07 | Methotrexate intrathecal | N | N | 330017566 | METHOTREXATE INTRATHECAL |
| 330008387 | 330005183 | null | 93 | Curative (C) | 2013-05-13 | 2013-05-15 | CAV | 02 | N | 330017571 | CISPLATIN + DOXORUBICIN |
| 330008388 | 330005184 | 1.96 | 112 | Palliative (P) | null | 2018-01-29 | Irinotecan + Temozolomide | 02 | N | 330017577 | IRINOTECAN + TEMOZOLOMIDE |
| 330008389 | 330005185 | 1.78 | 51.4 | Curative (C) | 2016-09-27 | 2016-10-07 | Liposomal Doxorubicin (Caelyx) | N | N | 330017579 | LIPOSOMAL DOXORUBICIN |
| 330008390 | 330005185 | 1.62 | 0 | Adjuvant (A) | 2013-09-04 | 2013-09-10 | Cisplatin + Doxorubicin | N | N | 330017579 | CISPLATIN + ETOPOSIDE |
| 330008391 | 330005185 | 1.67 | 69.4 | Curative (C) | 2014-04-09 | 2014-04-11 | Cisplatin + Etoposide (5 day) | N | N | 330017579 | CISPLATIN + ETOPOSIDE |
| 330008392 | 330005185 | null | 66.6 | Palliative (P) | 2015-08-05 | 2016-01-07 | Methotrexate intrathecal | Y | N | 330017579 | METHOTREXATE INTRATHECAL |
| 330008393 | 330005188 | 0 | null | Curative (C) | 2014-06-08 | 2014-06-13 | VAC | 02 | N | 330017649 | CISPLATIN + DOXORUBICIN |
| 330008394 | 330005188 | null | 93.3 | Palliative (P) | 2015-06-14 | 2015-06-18 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | null | 330017649 | VINBLASTINE |
| 330008397 | 330012499 | 0 | 104.8 | Neo-adjuvant (N) | 2015-09-24 | 2015-09-25 | NIVOLUMAB | N | N | 330017709 | VINBLASTINE |
| 330008398 | 330013070 | 1.5 | 75 | Disease modification (D) | 2015-01-12 | 2015-05-10 | Cisplatin + Doxorubicin | N | null | 330017721 | VINBLASTINE |
| 330008399 | 330005194 | 1.68 | 109.4 | Neo-adjuvant (N) | 2015-07-23 | 2015-07-23 | EW EuroEwing 2012 Arm A VIDE | N | null | 330017738 | EURO-EWING |
| 330008403 | 330005196 | null | 61 | Curative (C) | 2017-05-15 | 2017-05-20 | FLAG + Idarubicin | 02 | N | 330017787 | FLAG + IDARUBICIN |
| 330008404 | 330005197 | null | 63.5 | Palliative (P) | 2017-04-06 | 2017-06-06 | Cytarabine High Dose | N | N | 330017788 | CYTARABINE HIGH DOSE |
| 330008405 | 330005198 | 1.6 | 0 | Curative (C) | 2014-07-31 | 2014-08-01 | FLAG + Idarubicin | 2 | N | 330017789 | FLAG + IDARUBICIN |
| 330008406 | 330005198 | 1.82 | 109.2 | null | 2015-07-07 | 2015-08-09 | DA 3 + 10 | 02 | null | 330017789 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330008407 | 330005198 | null | 69 | Palliative (P) | 2017-05-23 | 2017-09-05 | FLAG + Idarubicin | N | N | 330017789 | FLAG + IDARUBICIN |
| 330008409 | 330005200 | 1.65 | 7.7 | Curative (C) | 2013-05-27 | 2013-06-11 | Cisplatin + Doxorubicin | N | N | 330017801 | VINBLASTINE |